✦ LIBER ✦
A phase I pharmacokinetic (PK) and serial tumor and skin pharmacodynamic (PD) study of weekly, every 2 weeks or every 3 weeks 1-hour (h) infusion EMD72000, an humanized monoclonal anti-epidermal growth factor receptor (EGFR) antibody, in patients (p) with advanced tumors known to overexpress the EGFR
- Book ID
- 117659560
- Publisher
- Elsevier Science
- Year
- 2002
- Tongue
- English
- Weight
- 256 KB
- Volume
- 38
- Category
- Article
- ISSN
- 0959-8049
No coin nor oath required. For personal study only.